Immunotherapy with chimeric NKG2D receptors leads to long-term tumor-free survival and development of host antitumor immunity in murine ovarian cancer. [electronic resource]
Producer: 20080310Description: 72-8 p. digitalISSN:- 0022-1767
- Animals
- Disease-Free Survival
- Female
- Granulocyte-Macrophage Colony-Stimulating Factor -- metabolism
- Immunotherapy, Adoptive -- methods
- Interferon-gamma -- metabolism
- Mice
- NK Cell Lectin-Like Receptor Subfamily K
- Ovarian Neoplasms -- therapy
- Perforin -- metabolism
- Receptors, Immunologic -- genetics
- Receptors, Natural Killer Cell
- Recombinant Fusion Proteins -- genetics
- T-Lymphocytes -- immunology
- Tumor Burden
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.